GUCY2C and irritable bowel syndrome: The synthetic GC‐C agonist peptide, linaclotide, is an FDA‐approved drug for adult patients with Irritable Bowel Syndrome with Constipation (IBS‐C) and Chronic Idiopathic Constipation (CIC) (Bryant et al.